Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats-Reference-Cited by-同舟云学术

Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats

Published:2017-01-04 Issue:1 Volume:12 Page:e0169588
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Otani Yuki,Yonezawa Atushi^ORCID,Tsuda Masahiro,Imai Satoshi,Ikemi Yasuaki,Nakagawa Shunsaku,Omura Tomohiro,Nakagawa Takayuki,Yano Ikuko,Matsubara Kazuo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. The safety and side effects of monoclonal antibodies;TT Hansel;Nat Rev Drug Discov,2010

2. Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics;J Golay;MAbs,2013

3. Simultaneous analysis of multiple monoclonal antibody biotherapeutics by LC-MS/MS method in rat plasma following cassette-dosing;H Li;Aaps j,2013

4. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry;M Qu;Mass Spectrom Rev,2016

5. Antibody structure, instability, and formulation;W Wang;J Pharm Sci,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 糖鎖が抗体医薬品を運ぶ;Drug Delivery System;2023-09-25

2. N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4;Pharmaceutical Research;2022-08-19

3. Therapeutic Drug Monitoring of Antibody Drugs;Biological and Pharmaceutical Bulletin;2022-07-01

4. Concentration and Glycoform of Rituximab in Plasma of Patients with B Cell Non-Hodgkin’s Lymphoma;Pharmaceutical Research;2019-04-15

5. Analysis of Glycoforms and Amino Acids in Infliximab and a Biosimilar Product Using New Method with LC/TOF-MS;Biological and Pharmaceutical Bulletin;2018-11-01